Avalon Invest Marketing Pricing 
socalTECH
JANUARY 17, 2017
San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00 as early as Thursday.
socalTECH
JANUARY 26, 2017
Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company now trades as ANAB on the NASDAQ Global Select Market. per share, at the midpoint of its $14.00
Expert insights. Personalized for you.
100 
Let's personalize your content